ArticleJournal for immunotherapy of cancer2020

Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice.

Michael John Zobel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.